Skip to main content
. 2018 Nov 15;17(2):247–252. doi: 10.1007/s40200-018-0366-2

Table 2.

Clinical characteristics by DM onset in pancreatic cancer patients

Variables DM Onset
Total (n = 58) Pre PCd (n = 33) At PCd (n = 10) Post PCd (n = 15) p value f-ratio value
Sex Male 36 (62.1) 19 (57.6) 8 (80.0) 9 (60.0) 0.433
Female 22 (37.9) 14 (42.4) 2 (20.0) 6 (40.0) 0.083
Site of Primary Tumour Head 38 (65.5) 22 (66.7) 4 (40.0) 12 (80.0) 0.117
Body 12 (20.7) 6 (18.2) 4 (40.0) 2 (13.3) 0.235
Tail 5 (8.6) 4 (12.1) 1 (10.0) 0 (0.0) 0.719
Unknown 3 (5.2) 1 (3.0) 1 (10.0) 1 (6.7) 0.653
Stage at PC Diagnosis Stage 1 3 (5.2) 2 (6.1) 1 (10.0) 0 (0.0) 0.766
Stage 2 15 (25.9) 8 (24.2) 0 (0.0) 7 (46.7) 0.115
Stage 3 13 (22.4) 7 (21.2) 1 (10.0) 5 (33.3) 0.379
Stage 4 26 (44.8) 15 (45.5) 8 (80.0) 3 (20.0) 0.013
Unknown 1 (1.7) 1 (3.0) 0 (0.0) 0 (0.0) 0.340
Surgery Yes 11 (19.0) 4 (12.1) 2 (20.0) 5 (33.3) 0.221
No 47 (81.0) 29 (87.9) 8 (80.0) 10 (66.7)
Chemotherapy Yes 42 (72.4) 20 (60.6) 8 (80.0) 14 (93.3) 0.053
No 16 (27.6) 13 (39.4) 2 (20.0) 1 (6.7)
Radiotherapy Yes 14 (24.1) 10 (30.3) 1 (10.0) 3 (20.0) 0.384
No 44 (75.9) 23 (69.7) 9 (90.0) 12 (80.0)
Mean Age (years) 68.5 67.8 67.1 70.9 0.515 0.671